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Abstract   
 
Background: Lack of health insurance may present a barrier to healthcare access for patients 
with acute coronary syndromes. Among interventional procedures, revascularization plays a 
critical role in treatment for acute coronary syndromes. A growing body of literature addresses 
outcome differences after percutaneous coronary intervention (PCI) between those with insurance 
and those without insurance. The purpose of this paper is to perform a systematic review of the 
literature examining how lack of health insurance is associated with mortality after percutaneous 
coronary intervention. 
Method: An electronic database literature search was performed using the terms “medically 
uninsured” and “angioplasty”. Further studies were identified from bibliographies of eligible 
studies.  Full-text articles were reviewed based on eligibility criteria. Excluded studies included 
those in non-U.S. settings, letters to the editor, review narratives, and those that did not explicitly 
report insurance status and PCI outcomes. Articles were critically appraised using the GRADE 
criteria. 
Results: Two observational cohort studies were analyzed. Both studies showed significantly 
greater rates of adjusted mortality after percutaneous coronary intervention for patients without 
insurance. Both studies had limitations common to those of observational studies. The quality of 
evidence was ultimately rated as moderate using the GRADE method. 
Conclusion: Assessment from two observational studies found that lack of health insurance was 
an independent risk factor for mortality following percutaneous coronary intervention. While no 
causal relationship can be drawn from this conclusion, mortality differences are likely associated 
with insurance-related disparities in healthcare access. Clinicians should consider patient-specific 
financial barriers, including lack of health insurance, when considering treatment and potential 
outcomes. Because so many Americans are uninsured and many are expected to remain 
uninsured, these types of studies have critical implications for healthcare reform.   
 
Keywords:  medically uninsured, angioplasty, percutaneous coronary intervention 
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Health Insurance and Mortality After Percutaneous Coronary 
Intervention: A Systematic Review 
 
BACKGROUND 
Healthcare insurance is a growing concern among the U.S. population and 
national health policy now explicitly addresses the disparity between insured and 
uninsured groups. An estimated 49.9 million Americans are uninsured.1 Socioeconomic 
factors influence the prevalence of cardiovascular disease, complications of which cost 
the national healthcare system an estimated $286.6 billion per year.2 Cardiovascular 
disease is the leading cause of death among adults,3 and over half of cardiovascular 
events are associated with coronary artery disease (CAD).2 Uninsured patients carry the 
burden of this, as lack of insurance is associated with higher mortality rates in patients 
with CAD,4,5 and a comparatively higher proportion of ED visits for acute myocardial 
infarction (MI).6  
Previous studies suggest that lack of health insurance may present a barrier to 
healthcare access for patients with acute complications of CAD or acute coronary 
syndromes such as MI or unstable angina. Smolderen et al7 demonstrated that, in acute 
MI patients, lack of health insurance was associated with greater pre-hospital delay,  
which likely puts these patients at risk for poorer outcomes. Most studies, however, have 
focused on patient outcomes after acute coronary events based on insurance status.8-­‐15  
Many of these suggest that uninsured patients are at greater risk for increased morbidity 
and mortality after MI.8,9,13-­‐15  
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Effective treatment modalities to reduce mortality after acute coronary events 
have been developed, but lack of health insurance may also present a barrier to healthcare 
interventions and treatment. Among interventional procedures, percutaneous coronary 
intervention (PCI) plays a critical role in treatment for acute coronary syndromes. Current 
ACC/AHA Guidelines recommend reperfusion therapy with PCI as first-line treatment 
for ST-segment elevation MI (STEMI).16 Specifically, PCI has been shown to decrease 
mortality after STEMI, and is particularly beneficial for the highest risk patients.16,17 And 
while increased use of guideline-recommended PCI has resulted in significantly 
decreased mortality in patients with ACS, there continues to be a disparity in its use.2 
Several studies have found that the uninsured in particular, are less likely to receive 
invasive cardiac procedures after MI.10,12,13,15,18,19 Only a few studies, however, have 
addressed outcome differences after PCI treatment based on insurance status.20,21 One 
hypothesized advantage to these studies is that potential confounders associated with 
healthcare access and types of treatment received are eliminated: all patients presented 
for and underwent revascularization with PCI. The purpose of this paper is to perform a 
systematic review of the literature examining how lack of health insurance affects 
mortality in patients after percutaneous coronary intervention.   
METHODS 
Literature Search and Selection 
An exhaustive literature search was performed using electronic databases and 
bibliographies of eligible studies. Electronic databases searched included MEDLINE, 
CINAHL, Evidence Based Medicine Reviews Multifile, and NCBI using the MeSH 
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terms “medically uninsured” and “angioplasty”. Titles and abstracts were screened for 
relevance and full-text articles were formally reviewed. Excluded studies were those in 
non-U.S. settings, letters to the editor, review narratives, and those that did not explicitly 
report insurance and PCI outcomes. 
Data Analysis 
Eligible articles were critically appraised using the GRADE criteria.22 
Specifically, studies were evaluated for potential limitations, consistency, directness, 
precision, and outcome analysis. GRADE methods were applied to upgrade or 
downgrade the studies, where necessary, and the quality of evidence was ultimately rated.   
RESULTS 
Systematic Review 
 The literature search produced 37 articles. Titles and abstracts of these articles 
were screened for relevance and 7 were excluded. Thirty full-text articles were formally 
reviewed and two studies were found eligible for inclusion in qualitative synthesis. Both 
of these articles were published in 2011 and were retrospective cohort studies. The 
quality of evidence was ultimately rated as moderate using the GRADE method. Findings 
were summarized and analysis presented, as shown in Table 1: Study Characteristics and 
Quality Assessment. 
Study Characteristics 
Gaglia et al  -- This retrospective cohort study20 analyzed data for 13 573 patients 
who underwent PCI at a single center between June 2000 and June 2009. Patients were 
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prospectively entered in the study and indicated for PCI based on stable or unstable 
angina, or acute MI. Baseline characteristics by insurance type included age, sex, race, 
ethnicity, clinical presentation, medical history risk factors, and specific procedural 
characteristics. The primary outcome measured was major adverse cardiac events 
(“MACE”), as measured up to 1-year post-PCI. The study defined MACE as a composite 
of all cause mortality, Q-wave myocardial infarction, and target vessel revascularization.  
A central database center managed and analyzed all clinical, procedural, follow-up, and 
insurance data collected from hospital charts, office visits, and phone interviews.  
Outcomes were recorded up to 1-year post-PCI.20 
Statistical adjustment for baseline characteristics was performed using multivariable 
Cox regression analyses. Separate analyses were performed for patients <65 years old 
and ≥65 years old, as uninsured patients were included only in the younger age group 
analysis.  Of the 13 573 patients included in the study, 284 (2.1%) were uninsured. 
Uninsured patients were more likely to have received a glycoprotein IIb/IIIa inhibitor 
versus bivalirudin and a bare metal stent versus a drug-eluting stent. Analyses included 
univariate outcomes by insurance type, Kaplan-Meier survival probability, and adjusted 
hazard ratios for MACE at 1 year. Overall, this study showed significantly greater rates 
of mortality in-hospital and up to 1 year after PCI for patients without insurance 
compared to those with private insurance in the age group <65 years old (HR 2.41, 95% 
CI 1.36 - 4.27).20 
Parikh et al -- This retrospective cohort study21 analyzed data for 13 456 patients 
who underwent PCI at four New York State hospitals between January 1, 2004 and 
December 31, 2007. Baseline characteristics by insurance type included age, sex, race, 
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ethnicity, clinical presentation, medical history risk factors, urgency for PCI, and specific 
procedural characteristics. Medicare patients were excluded. The primary outcome 
measured was in-hospital all cause mortality post-PCI. A central database center 
managed and analyzed all data collected from hospital charts. Outcomes were recorded 
through patient hospital stay.21 
Statistical adjustment for baseline characteristics was performed using multivariable 
logistic regression analyses. Of the 13 456 patients included in the study, 493 (3.7%) 
were uninsured. Uninsured patients were more likely to have received a bare metal stent 
versus a drug-eluting stent. Analyses included univariate in-hospital outcomes by 
insurance type, adjusted odds ratios for all cause in-hospital mortality, and a subset 
adjusted odds ratio for patients undergoing emergent PCI. Overall, this study showed 
significantly greater rates of adjusted in-hospital mortality after PCI for patients without 
insurance (OR 3.02, 95% CI 1.10 - 8.28).21 
DISCUSSION 
From this systematic review, lack of health insurance was an independent risk 
factor for mortality following percutaneous coronary intervention. Evidence for mortality 
following PCI was of moderate quality according to the GRADE approach. Ultimately, 
findings from these observational studies agreed with findings from other studies 
evaluating mortality outcomes among the uninsured. 
Because mortality is strongly influenced by age, these studies importantly 
differentiated patients >65 years old or with Medicare by separate analysis or exclusion, 
respectively. And while other baseline characteristics within the <65 year old group were 
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statistically adjusted for, their differences hold important relevance. For example, 
uninsured patients studied by Parikh et al21 tended to present with comparatively reduced 
left ventricular ejection fractions and more advanced CAD for age. Similar differences 
were found in baseline characteristics of the BARI2D revascularization trial,23 where 
uninsured patients presented with more cardiovascular risk factors and poorer baseline 
status of CAD. Other differences may be found at the provider-level, as demonstrated by 
both studies analyzed here, where uninsured patients were less likely to receive drug-
eluting stents.20,21 Amin et al8 identified another potential disparity by addressing 
healthcare follow-up. In this study, “noncompliance” (missing follow-up appointments, 
failing to fill medications) post-MI was associated with increased mortality among 
uninsured patients. Such differences may point toward a multifactorial etiology of 
insurance-based disparities with regard to patient mortality. The uninsured may not be 
receiving ambulatory care that would potentially identify and treat risk factors 
contributing to CAD, and so are presenting for invasive intervention with higher disease 
burdens. Additionally, the uninsured may be receiving a different quality of care and/or 
not receiving adequate follow-up. 
Limitations 
Although these studies were large, they had the limitations of nonrandomized 
observational studies, including uncontrolled confounding and misclassification bias.  
However, due to the nature of studies investigating harm outcomes, randomized studies 
may not be performed. Ultimately, findings from both of these studies agreed with 
findings from other studies evaluating mortality outcomes among the uninsured.  
	   13	  
Prognostically different baseline characteristics between patient groups are 
inherent to studies of this type. When these were controlled for, statistical analyses were 
still significant. Between studies, there were small differences in the baseline medical 
history that were controlled for. Gaglia et al20 additionally evaluated hypertension, 
dyslipidemia, and smoking status as risk factors; whereas Parikh et al21 evaluated prior 
MI and stroke characteristics. Potentially, there were unrecognized baseline 
characteristics between insurance groups, or medical history that was unrecognized by 
the patients themselves. For example, those without prior healthcare, like the uninsured, 
may not have had a documented history or personal knowledge about existing 
hypertension. There was also variability in patient treatments. In both studies, uninsured 
patients were more likely to receive bare metal stents versus drug-eluting stents.20,21 
Gaglia et al20 further reported that uninsured patients were more likely to receive a 
glycoprotein IIb/IIIa inhibitor than bivalirudin.  
Other potential limitations included short follow-up by the Parikh et al study,21 
and potential bias due to the small number of uninsured patients within larger study 
populations. Results were statistically significant, as demonstrated by the hazard and 
odds ratios, although wide confidence intervals indicated less precision. Finally, these 
studies likely underestimated the mortality associated with lack of insurance because only 
patients who accessed the healthcare system were measured. The potential group of 
uninsured patients who were not admitted, died pre-hospital, or had CAD but were not 
treated with PCI were left unmeasured. 
Recommendations for Further Study 
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Further studies are needed to address the disparities associated with healthcare 
outcomes and insurance status. A meta-analysis and systematic review evaluating post-
MI mortality among uninsured patients may provide significant clinical and policy-
making implications. Further studies are also needed to assess long-term outcomes, such 
as barriers to medications and follow-up, problems with pre-hospital and ambulatory 
access, long-term differences using specific cardiac interventions, and cause-specific 
mortality. 
Lack of insurance is associated with morbidity and mortality,24,25 which suggests 
that universal health coverage could save lives. But, studies that evaluated socioeconomic 
status, versus insurance status alone, show that we may be underinsuring.5,7,14 Rahimi et 
al14 found that patients with self-reported financial barriers, 68.9% of whom were actually 
insured, had worse outcomes post-MI. Horne et al5 also demonstrated that socioeconomic 
status was an independent risk factor for mortality in patients with CAD. The concept of 
underinsurance is further supported by data that suggest that Medicaid patients are at as 
great a risk for mortality as the uninsured. Medicaid patients  <65 years old were at 
comparatively increased risk for mortality following PCI in both studies evaluated 
here.20,21 Other studies support these findings, reporting outcome and treatment 
differences among Medicaid patients.10-­‐12 Further studies that control for potential 
confounders associated with the Medicaid cohort, such as chronic or congenital 
problems, are needed. 
Evidence from countries with forms of universal health coverage also suggests 
that socioeconomic status is associated with adverse cardiovascular outcomes.26-­‐29 In a 
study from Canada, Alter et al26 found that socioeconomic status was associated with 
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increased mortality up to one year after MI. Their results even demonstrated a dose-
response, where each established increase in income was associated with reduced 
mortality.  A long-term study from Israel by Gerber et al29 showed similar outcomes, 
where socioeconomic status was strongly associated with mortality up to 13 years post-
MI. Such studies expose how insurance status alone may not eliminate financial barriers 
to healthcare access, treatment, and outcomes. These results may have implications for 
the quality of insurance that is developed and maintained by healthcare policy, as well as 
the public support provided to patients with socioeconomic barriers to healthcare. 
CONCLUSION 
Assessment from a systematic review of two observational studies found that lack 
of health insurance was an independent risk factor for mortality following percutaneous 
coronary intervention. While no causal relationship can be drawn from this conclusion, 
mortality differences are likely associated with insurance-related disparities in healthcare 
access. Clinicians should consider patient-specific financial barriers, including lack of 
health insurance, when considering treatment and potential outcomes. Because so many 
Americans are uninsured and many are expected to remain so, these types of studies have 
critical implications for healthcare reform.   
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